NEOPLASM METASTASIS
Clinical trials for NEOPLASM METASTASIS explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM METASTASIS trials appear
Sign up with your email to follow new studies for NEOPLASM METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer patients get continued access to promising drug in extension trial
Disease control OngoingThis study offers continued treatment with trastuzumab emtansine (alone or with other cancer drugs) to people with metastatic cancer who were already benefiting from it in a previous study. About 720 participants worldwide are included. The main goal is to monitor safety and side…
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New pill shows promise against Hard-to-Treat HER2 cancers
Disease control OngoingThis early-stage study tests a new daily pill, zongertinib, for people with advanced solid tumors (including lung cancer) that have HER2 gene changes. The first part finds the best dose, and the second part checks if the drug can shrink tumors. Participants stay on treatment as l…
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 26, 2026 03:22 UTC
-
Hope for tough childhood cancer: new combo targets relapsed Ewing's sarcoma
Disease control OngoingThis study tests whether adding the drug abemaciclib to standard chemotherapy can help children and young adults with Ewing's sarcoma that has returned or not responded to treatment. About 46 participants will receive either the new combination or chemotherapy alone. The goal is …
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New drug targets hard-to-treat cancers in major clinical trial
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with advanced cancers that have stopped responding to standard treatments. The goal is to see if the drug is safe and can help control the cancer. About 350 people with various cancer types, …
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Hope for advanced breast cancer: new combo targets resistant tumors
Disease control OngoingThis phase 3 study tests whether adding abemaciclib to fulvestrant can slow or stop the growth of a common type of advanced breast cancer (HR+, HER2-) that has worsened despite prior treatment with CDK4/6 inhibitors and hormone therapy. About 368 participants will receive either …
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New hope for Hard-to-Treat cancers: experimental drug MK-6837 enters human testing
Disease control OngoingThis early-stage study tests an experimental drug called MK-6837, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks …
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
Sound waves vs. bone pain: new combo treatment tested
Symptom relief OngoingThis study tests whether focused ultrasound (MR-HIFU), alone or with standard radiation, can better relieve bone pain caused by cancer that has spread. About 216 adults with painful bone lesions will be randomly assigned to one of three groups. The goal is to see if adding ultras…
Matched conditions: NEOPLASM METASTASIS
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated May 26, 2026 03:14 UTC